Carrie Whitney‐Pickett

Development of a new permeability assay using low‐efflux MDCKII cells

Li Di, Carrie Whitney‐Pickett, John P. Umland et al. · Journal of Pharmaceutical Sciences · 2011 · 317 citations

Pharmacy, Cell Biology, Cell Biophysics +10

pH-Dependent Solubility and Permeability Criteria for Provisional Biopharmaceutics Classification (BCS and BDDCS) in Early Drug Discovery

Manthena V. S. Varma, Iain Gardner, Stefanus J. Steyn et al. · Molecular Pharmaceutics · 2012 · 164 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

The JAK-3 inhibitor CP-690550 is a potent anti-inflammatory agent in a murine model of pulmonary eosinophilia

Elizabeth M. Kudlacz, Maryrose J. Conklyn, Catharine J. Andresen et al. · European Journal of Pharmacology · 2008 · 97 citations

Life Sciences, Immunology, Pharmacology +17

Optimization of the physicochemical and pharmacokinetic attributes in a 6-azauracil series of P2X7 receptor antagonists leading to the discovery of the clinical candidate CE-224,535

Allen J. Duplantier, Mark A. Dombroski, Chakrapani Subramanyam et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 75 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Discovery, synthesis and SAR of azinyl- and azolylbenzamides antagonists of the P2X7 receptor

Chakrapani Subramanyam, Allen J. Duplantier, Mark A. Dombroski et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 20 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13